Conmed closes $145M acquisition of orthopedic devicemaker

Carly Behm -  

Conmed completed its $145 million acquisition of In2Bones, a devicemaker focused on upper and lower extremities.

Conmed's 2.2 percent convertible notes are funding the transaction, according to a June 13 news release. In2Bones' portfolio includes implants, fracture systems and biologic products.

The deal was announced in May. The acquisition includes up to an additional $110 million in growth-based earnout payments over four years.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Podcast

Featured Whitepapers